| Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
11,441,326 |
$45,780,178 |
$4.00 |
06 Jun 2023 |
By Flagship VentureLabs V, LLC |
| Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
10,743,293 |
$42,987,138 |
$4.00 |
07 Jun 2023 |
By Flagship Ventures Fund V, L.P. |
| Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
9,725,122 |
$38,913,131 |
$4.00 |
06 Jun 2023 |
By Flagship Pioneering Fund VI, L.P. |
| Sana Biotechnology, Inc. |
10%+ Owner |
Common Stock |
1,380,277 |
$5,522,902 |
$4.00 |
07 Jun 2023 |
By Flagship V VentureLabs Rx Fund, L.P. |
| Codiak BioSciences, Inc. |
10%+ Owner |
Common Stock |
1,865,767 |
|
|
15 Sep 2022 |
By Flagship Ventures Fund V, L.P. |
| Codiak BioSciences, Inc. |
10%+ Owner |
Common Stock |
1,188,920 |
|
|
15 Sep 2022 |
By Flagship V VentureLabs Rx Fund, L.P. |
| Codiak BioSciences, Inc. |
10%+ Owner |
Warrants to purchase Common Stock |
722,590 |
|
|
15 Sep 2022 |
By Flagship Ventures Fund V, L.P. |
| Codiak BioSciences, Inc. |
10%+ Owner |
Common Stock |
485,949 |
|
|
15 Sep 2022 |
Flagship VentureLabs V LLC |
| Codiak BioSciences, Inc. |
10%+ Owner |
Warrants to purchase Common Stock |
210,743 |
|
|
15 Sep 2022 |
By Flagship V VentureLabs Rx Fund, L.P. |
| Sigilon Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$14.92 |
11 Aug 2023 |
By Flagship Pioneering Special Opportunities Fund II, L.P. |
| Sigilon Therapeutics, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$14.92 |
11 Aug 2023 |
By Flagship Ventures Fund V, L.P. |